Current through Supplement No. 394, October, 2024
Section 20-02-01-13 - Exceptions to the review requirementA practitioner may not be required to review a patient's prescription drug monitoring program data if any of the following apply:
1. The controlled substance is prescribed or dispensed for a patient who is currently receiving hospice care.2. The controlled substance is prescribed or dispensed to a patient of record as a nonrefillable prescription as part of treatment for a surgical procedure.3. The dentist prescribes a controlled substance after the performance of oral surgery and no more than a seventy-two hour supply of the controlled substance is prescribed.4. The dentist prescribes pre-appointment medication for the treatment of procedure anxiety.5. The dentist obtains a report through a board-approved risk assessment tool for health care providers that accesses patient prescription information from prescription drug monitoring program databases, analyzes the data, and provides a risk-based score that includes prescription drug monitoring program data.N.D. Admin Code 20-02-01-13
Adopted by Administrative Rules Supplement 2017-365, July 2017, effective 7/1/2017.General Authority: NDCC 43-28-01(7), 43-28-06
Law Implemented: NDCC 19-03.5-09, 43-28-06(1)